TZIANABOS ARTHUR
Interim Executive Chair
TZIANABOS ARTHUR has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Mar 12, 2026.
On the most recent filing, TZIANABOS ARTHUR is listed as Interim Executive Chair at Stoke Therapeutics, Inc. Inside the rolling window, TZIANABOS ARTHUR reported no open-market purchases and 1 open-market sale totaling $174K in STOK.
Companies traded
Other insiders at STOK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$174K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has TZIANABOS ARTHUR made?
TZIANABOS ARTHUR has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does TZIANABOS ARTHUR trade?
TZIANABOS ARTHUR has filed SEC Form 4 disclosures for 1 company, including STOK.
When was TZIANABOS ARTHUR's most recent SEC Form 4 filing?
TZIANABOS ARTHUR's most recent SEC Form 4 filing on Tracefour is dated Mar 12, 2026.
What is TZIANABOS ARTHUR's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, TZIANABOS ARTHUR is listed as Interim Executive Chair.
What is TZIANABOS ARTHUR's total buy and sell value in the current window?
Inside the rolling retention window, TZIANABOS ARTHUR bought $0 and sold $174K based on SEC Form 4 filings.
What was TZIANABOS ARTHUR's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,355 STOK shares on 2026-03-10, worth $174K, per SEC Form 4 filings.